Clinical Trials Browser

Atorvastatin × Gastrointestinal × Clear all

NCT04767984 2026-01-21

Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis

Phase 2 Active not recruiting

Gastrointestinal

Colitis, Ulcerative, Colorectal Neoplasms

NCT04379999 2025-08-07

Atorvastatin ± Aspirin in Lynch Syndrome Syndrome

Phase EARLY_PHASE1 Completed

Gastrointestinal

Colorectal Neoplasms, Hereditary Nonpolyposis

NCT03024684 2024-11-12

SHOT

Phase 4 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT04862260 2024-05-22

Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma

Phase EARLY_PHASE1 Active not recruiting

Gastrointestinal

Hyperlipoproteinemia Type II, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT02201381 2022-07-18

METRICS

Phase 3 Withdrawn

BreastCNSGastrointestinalGynecologic

Brain Neoplasms, Breast Neoplasms, Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Triple Negative Breast Neoplasms

NCT04151355 2019-11-05

Effect of Atorvastatin on 5-Fluorouracil Induced Mucositis

Phase NA Unknown

Gastrointestinal

Colorectal Neoplasms

NCT00335504 2017-02-15

Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia

Phase 2 Completed

85 enrolled 10 charts

GastrointestinalOther neoplasm

Colonic Neoplasms, Precancerous Conditions, Rectal Neoplasms

NCT01605344 2014-02-27

Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI

Phase 1 Withdrawn

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms